Clinical Trial Update: Study Of Effects Of Oral CREON Capsules In Adult Participants With Exocrine Pancreatic Insufficiency Not Due To Cystic Fibrosis, Chronic Pancreatitis, Pancreatectomy, Or Pancreatic Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial of oral CREON capsules in adults with Exocrine Pancreatic Insufficiency has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Exocrine Pancreatic Insufficiency

Drugs mentioned

• Creon (pancrelipase)

Snippet

Sponsor: AbbVie | Conditions: Exocrine Pancreatic Insufficiency (EPI) | Phase 4 | Status: WITHDRAWN